XYLO TECHNOLOGIES LTD EXPLANATORY NOTE
Medigus Ltd. (the "Company"), hereby announces that the shareholders of the Company approved all the proposals brought before the annual general meeting of shareholders scheduled for August 7, 2023 and adjourned to August 8, 2023 (the "Meeting"), as originally proposed and included in the Company's proxy statement for the Meeting, that was attached as Exhibit 99.1 to a Report of Foreign Private Issuer on Form 6-K that the Company furnished to the Securities and Exchange Commission on June 30, 2023.
25,694,490 ordinary shares, representing approximately 9.94% of the Company's issued and outstanding ordinary shares as of the record date, were present or represented by proxy at the Meeting.
This Form 6-K is incorporated by reference into the Company's Registration Statements on Form S-8 (File Nos. 333-258624, 333-206803, 333-221019 and 333-229429).
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Medigus Ltd. published this content on 08 August 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 August 2023 23:59:35 UTC.
